Publications in collaboration with researchers from Clínica Universitaria de Navarra (8)

2024

  1. An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

    International Journal of Gynecological Cancer, Vol. 34, Núm. 6, pp. 942-945

  2. Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

    Journal of Clinical Oncology, Vol. 42, Núm. 36, pp. 4294-4304

  3. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer

    Seminars in Oncology Nursing, Vol. 40, Núm. 1

  4. Immunotherapy. Aparadigmshiftinthetreatmentofcervicalcancer

    Revisiones en Cancer, Vol. 38, Núm. 5, pp. 198-207

  5. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

    Clinical and Translational Oncology, Vol. 26, Núm. 12, pp. 3211-3217

  6. SENECA study: staging endometrial cancer based on molecular classification

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 34, Núm. 9, pp. 1313-1321

  7. SEOM-GEICO Clinical Guidelines on cervical cancer (2023)

    Clinical and Translational Oncology, Vol. 26, Núm. 11, pp. 2771-2782

2019

  1. Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?

    Cancer, Vol. 125, Núm. S24, pp. 4616-4622